[HBC] Life Science Investing

Join us for our open-community keynote address of the HBC “Investing in Publicly-Traded Biotechnology Companies” course given by Dr. Ricky Sun! Ricky joined Bain Capital in 2016 and he is a Partner on the Life Sciences team. Prior to joining Bain Capital, Ricky was a Director of Corporate Development and Strategy at Biogen. Prior to Biogen, he served as a Vice President at BlackRock, as a member of the Fundamental Equity division of BlackRock's Alpha Strategies Group, and senior analyst for BlackRock's Fundamental Large Cap Growth equity team, covering the health care sector. Ricky received a PhD degree in chemistry and chemical biology from Harvard University and was an NIH post-doctoral fellow in biological chemistry and molecular pharmacology at Harvard Medical School.